DJDoha Marrakchi Ben Jaafar

Doha Marrakchi Ben Jaafar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Doha Marrakchi Ben Jaafar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Alae Chda

    Laboratory of Microbial Biotechnology and Bioactive Molecules, Faculty of Sciences and Technologies Faculty, Sidi Mohamed Ben Abdellah University, P.O. Box 2202, Imouzzer Road, Fez, Morocco

    2 shared publications
  • Rachid Bencheikh

    Laboratory of Microbial Biotechnology and Bioactive Molecules, Faculty of Sciences and Technologies Faculty, Sidi Mohamed Ben Abdellah University, P.O. Box 2202, Imouzzer Road, Fez, Morocco

    2 shared publications
  • Youssef Mahou

    Laboratory of Microbial Biotechnology and Bioactive Molecules, Faculty of Sciences and Technologies Faculty, Sidi Mohamed Ben Abdellah University, P.O. Box 2202, Imouzzer Road, Fez, Morocco

    2 shared publications
  • Andreia P. Oliveira

    REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, R. Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal

    1 shared publication
  • Aziz El Bouri

    Institut de Criminalistique de La Gendarmerie Royale, BP 6597 Rabat-Instituts, Rabat, CP 10000, Morocco

    1 shared publication
  • Hamid Stambouli

    Institut de Criminalistique de La Gendarmerie Royale, BP 6597 Rabat-Instituts, Rabat, CP 10000, Morocco

    1 shared publication

Latest Publications

  • Open Access

    Endothelium-dependent and adrenergic involvement in the biphasic vascular effects of a phenolic-rich ethanolic fraction from male Cannabis sativa inflorescences

    by Doha Marrakchi Ben Jaafar, Youssef Mahou, Alae Chda, Mohamed Chebaibi, Andreia P. Oliveira, Nelson G.M. Gomes, Paula B. Andrade, Rachid Bencheikh

  • Open Access

    Chemical profile and bioactive properties of Cannabis sativa threshing residue: Vasorelaxant, antioxidant, immunomodulatory, and antibacterial activities

    by Youssef Mahou, Doha Marrakchi Ben Jaafar, Nada Al Moudani, Mohamed Jeddi, Alae Chda, Nezha Fettoukh, Kawtar Fikri Benbrahim, Lotfi Aarab, Aziz El Bouri, Hamid Stambouli, et al.

    Introduction: Cannabis sativa threshing residue is the plant material left after extracting resinous trichomes from the dried female plant. This study examines the phytochemical properties of C. sativa threshing residue and screens its vasorelaxant, antimicrobial, and immunomodulatory activities. Methods: The residue was extracted sequentially using hexane, dichloromethane, ethyl acetate, and ethanol. The four fractions were analyzed by gas chromatography-mass spectrometry. Phenolic and flavonoid contents were estimated using Folin-Ciocalteu reagent and aluminum chloride colorimetric methods. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay determined in vitro antioxidant activity. The vasorelaxant effect was explored using rat mesenteric arterial beds (MABs). Antimicrobial studies on Salmonella enterica, Escherichia coli, Staphylococcus aureus, and Bacillus cereus were conducted using microdilution tests. Immunomodulatory activity was determined using cell proliferation, antibody production, and complement tests. Results: Phytochemical analysis of the four fractions revealed many volatile bioactive compounds, including terpenes like phytol and squalene and cannabinoids like delta-9-tetrahydrocannabinol and cannabidiol (CBD). The fractions had significant polyphenol and flavonoid content. They dose-dependently dilated the MAB and demonstrated varying DPPH free radical scavenging activity. Immunomodulatory activity showed an immunosuppressive effect on cell proliferation and biological functions. The four bacterial strains studied were sensitive to the fractions but with different degrees. Conclusion: Cannabis sativa threshing residue demonstrated diverse pharmacological potential, suggesting its suitability for developing cannabis-based medications targeting hypertension-related damage, free radicals, and bacteria, expanding its potential applications beyond inflammation-related conditions